<DOC>
	<DOCNO>NCT00972842</DOCNO>
	<brief_summary>A standard therapy neither establish first-line patient relapse patient PTCL , still unmet medical need identify novel efficacious safe therapy regimen . The aim study evaluate potential Lenalidomide plus Vorinostat Dexamethasone combination therapy effective safe therapeutic regimen , treatment relapse PTCL follow failure prior regimen .</brief_summary>
	<brief_title>Lenalidomide , Vorinostat Dexamethasone Relapsed Patients With Peripheral T-Cell Non-Hodgkin 's Lymphoma ( PTCL )</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Lenalidomide</mesh_term>
	<mesh_term>Vorinostat</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>Patients relapse PTCL accord WHO criteria receive max . two previous treatment PTCL Age ≥ 18 year . Adequate bone marrow function i.e . absolute neutrophile count &gt; 1000/µl thrombocyte &gt; 75,000/µl . Alkaline phosphatase transaminases ≤ 2,5 x upper limit normal ( ULN ) Total bilirubin ≤ 2,5 x ULN Creatinine clearance ≥ 50 ml/min Female subject childbearing potential† must : Understand study medication could expect teratogenic risk agree use , able comply , effective contraception agree medically supervised pregnancy test Male subject must agree use condom agree donate semen Prior history malignancy , PTCL , unless subject free disease ≥ 3 year Prior allogeneic bone marrow transplant plan undergo autologous/ allogeneic bone marrow transplant within 4 week initiation vorinostat administration Prior treatment HDAC inhibitor Prior treatment Lenalidomide ( patient previously treat Thalidomide may enrol ) Known history Deep Vein Thrombosis ( DVT ) and/ pulmonary embolism ( PE )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>PTCL</keyword>
	<keyword>Peripheral T-Cell Non-Hodgkin 's Lymphoma</keyword>
	<keyword>Vorinostat</keyword>
	<keyword>Lenalidomid</keyword>
</DOC>